They are the pharmaceutical physicians, often based in different Indian states. They interact with physicians on investigator-initiated studies, Baricitinib scientific communication, research activities, capacity building, and pipelines in the drug development. Even as sales representatives are required to restrict discussion to the approved prescribing information of a marketed product, medical liaisons can discuss and exchange scientific information related to other topics, including recent advances, research methodology, and so on. In India, it is observed that physicians, because of their limited time, are sometimes unable to update themselves on the current developments in the medical field. Therefore, they look for medical liaisons to provide scientific information, which could really be of use to them in treating their patients better.
New product launch Launching a new pharmaceutical product is a collaborative effort of regulatory, marketing, medical, and other functions in the pharmaceutical company. The process requires detailed planning, and also effective execution. Many critical activities take place well in advance of the actual launch of a new product. Each of these activities is time bound and has a set of objectives. The activities are divided into prelaunch, launch, and post launch activities. Prelaunch The role of a medical advisor includes highlighting the advantages of the new medicine, providing inputs on the exact medical positioning of the product, and discussing the possible high science / medical services that can be associated with the medicine.
These discussions can be either one-on-one with practicing physicians or in form of advisory boards. The boards must include physicians of highest repute such as academicians, those having interest in original research and publications in their respective Brefeldin_A therapy area. Medical advisors often coordinate these programs and share new data available in different indications. Launch During launch, the medical advisor has a dual role. Internally, he is responsible for training of medical representatives, approving promotional material and medical inputs. Externally, he acts as the face of the organization by exposing much higher number of physicians to the product, addressing queries of physicians on usage of the medicine in patients and participating in physician meetings.
Post launch In the post launch phase, it is important to update physicians on emerging information, answer queries on the drug’s safety and efficacy profile. In addition, Bortezomib msds currently, medical advisors play an important role in partnering with physicians on investigator ?C initiated research and epidemiological studies which is the real need in India. Interactions with stakeholders Medical advisor is a critical link between a pharmaceutical company and external stakeholders [Figure 1]. External stakeholders include regulatory agencies, physicians, hospital administrators and patient groups.